The primary mission of the Research & Development (R&D) division of the Stago Group is to design automatic analyzers, reagents, consumables, and services, focused on meeting the needs of healthcare providers, with the goal of improving treatment for clotting disorders and thrombosis. Working alongside the scientific community, R&D also focuses on identifying and studying new markers and methods.
Since 1962, the Stago Group has concentrated its attention on biology, specializing in the "emerging" sector of hemostasis. Thanks to this clear focus, the group is now recognized worldwide by the scientific community.
Stago continues to maintain and develop strong links with the hemostasis community on a day-to-day basis by: